Abstract
Hypoxia is the fundamental stimulus for erythropoietin (Ep) production (Fisher 1983, 1988; Kurz et al. 1986). Our model for kidney Ep production postulates that an oxygen deficit initiates a cascade of events which lead to increased biosynthesis and secretion of Ep. The physiologic and pathophysiologic control involved is still not clearly understood. However, there is a primary oxygen-sensing reaction in the kidney which is triggered by a reduction in ambient partial pressure of oxygen (high altitude, hypobaria); a decreased passage of oxygen across the pulmonary endothelium (obstructive lung disease); a decrease in the oxygen-carrying capacity of hemoglobin (anemia); a decrease in oxygen utilization by the kidney (cobalt) (Fisher and Birdwell 1961); and a decrease in the flow of blood to the kidney (renal artery constriction, atherosclerosis, thrombosis).
Supported by USPHS grant DK13211 and Private funds
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beauchamp C, Fridovich I (1970) A mechanism for the production of ethylene from methional: the generation of hydroxyl radicals by xanthine oxidase. J Biol Chem 245:4641
Berridge MJ (1984) Inositol triphosphate and diacylglycerol as second messengers. SOD Biochem J 222:345–360
Daly JW (1982) Receptors: targets for future drugs. J Med Chem 25:197–207
Dionisi O, Galeotti T, Terranova T, Azzi A (1975) Superoxide radicals and hydrogen peroxide formation in mitochondria from normal and neoplastic tissues. Biochim Biophys Acta 403:292
Fink GD, Fisher JW (1977) Stimulation of erythropoiesis by beta adrenergic agonists. II. Mechanism of action. J Pharmacol Exp Ther 202:199–208
Fink GD, Paulo LG, Fisher JW (1975) Effects of beta-adrenergic blocking agents on erythropoietin production in rabbits exposed to hypoxia. J Pharmacol Exp Ther 193:176–181
Fisher JW (1983) Control of erythropoietin production. Proc Soc Exp Biol Med 173:289–305
Fisher JW (1988) Pharmacologic modulation of erythropoietin production. Annu Rev Pharmacol Toxicol 28:101–122
Fisher JW, Birdwell BJ (1961) The production of an erythropoietin factor by the in situ perfused kidney. Acta Haematol (Basel) 26:224–232
Fisher JW (1991) Regulation of erythropoietin (Ep) production. In: Handbook of renal physiology. Oxford University Press, New York (in press)
Goldberg MA, Glass A, Cunningham JM, Bunn HF (1987) The regulated expression of erythropoietin by two human hepatoma cell lines. Proc Natl Acad Sci USA 84:7972–7976
Guilbert LJ, Iscove NN (1976) Partial replacement of serum by selenite, transferrin, albumin and lecithin in haemopoietic cell cultures. Nature 263:594–595
Hagiwara M, Pincus SM, Chen I-L, Beckman BS, Fisher JW (1985) Effects of dibutyryl adenosine 3’-5’-cycHc monophosphate on erythropoietin production in human renal carcinoma cultues. Blood 66:714–17
Hagiwara M, Nagakura K, Ueno M, Fisher JW (1987) Inhibitory effects of tetra-decanoylphorbol acetate and diacylglycerol on erythropoietin production in human renal carcinoma cell cultures. Exp Cell Res 173:129–136
Huang S, Sun GY (1986) Cerebral ischemia induced quantitative changes in rat membrane lipids involved in phosphoinositide metabohsm. Neurochem Int 9:185–190
Jones DP (1986) Renal metabolism during normoxia, hypoxia, and ischemic injury. Annu Rev Physiol 48:33–50
Knowles BB, Howe CC, Aden DP (1980) Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209:497–499
Kurz AW, Jelkmann A, Pfuhl K, Malmstrom K, Bauer C (1986) Erythropoietin production by fetal mouse liver cells in response to hypoxia and adenylate cyclase. Endocrinology 118:567–572
Londos C, Wolff J (1988) Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci USA 74:5482–5486
Londos C, Cooper DMF, Wolff J (1980) Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77:2551–2554
McCord JM (1985) Oxygen derived free radicals in postischemic tissue injury. N Engl J Med 312:159–163
Miller WL, Thomas RA, Berne RM, Rubia R (1978) Adenosine production in the ischemic kidney. Circ Res 43:390–397
Nelson JA, Drake S (1984) Potentiation of methotrexate toxicity by dipyridamole. Cancer Res 44:2493–2496
Nelson PK, Brookins J, Fisher JW (1983) Erythropoietin effects of prostacyclin (PGI2) and its metabolite 6-keto-prostaglandin (PGi) E. J Pharmacol Exp Ther 226:493–499
Nielsen OJ, Schuster SJ, Kaufman R, Erslev AJ, Caro J (1987) Regulation of erythropoietin production in a human hepatoblastoma cell line. Blood 70: 1904–1909
Osswald H, Schmitz HJ, Kemper R (1977) Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and post-ischemic recirculation. Pflugers Arch 371:45
Paul P, Rothmann SA, Meagher RC (1988) Modulation of erythropoietin production by adenosine. J Lab CHn Med 112:168–173
Rodgers GM, Fisher JW, George WJ (1975a) Increase in hematocrit hemoglobin and red cell mass in normal mice after treatment with cyclic AMP. Proc Soc Exp Biol Med 148:380–382
Rodgers GM, Fisher JW, George JW (1975b) The role of renal adenosine 3’,5’-monophosphate in the control of erythropoietin production. Am J Med 58:31
Rodgers GM, Fisher JW, George WJ (1976) Renal cyclic GMP and cholinergic mechanisms in erythropoietin production. Life Sci 17:1807–1814
Seamon KB, Padgett W, Daly JW (1981) Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci USA 78:3363–3367
Shah SV (1984) Effect of enzymatically generated reactive oxygen metabolites on the cyclic nucleotide content in isolated rat glomeruli. J Clin Invest 74:393–401
Sherwood JB, Burns ER, Shouval D (1987) Stimulation by cAMP of erythropoietin secretion by an established human renal carcinoma cell line. Blood 69:1053–1057
Smith RJ, Fisher JW (1976) Neutral protease activity and erythropoietin production in the rat after cobalt administration. J Pharmacol Exp Ther 197:714–722
Spielman WS (1984) Antagonistic effect of theophylline on the adenosine-induced decrease in renin release. Am J Physiol 247:F246-F251
Strosznajder J, Wikiel H, Sun GY (1987) Effects of cerebral ischemia on [3H] inositol lipids and [3H] inositol phosphate of gerbil brain and subcellular fractions. J Neurochem 48:943–949
Toledo-Pereyra LH, Simmons RL, NajarÃan JS (1974) Effects of allopurinol on the preservation of ischemic kidneys perfused with plasma or plasma substitutes. Ann Surg 180:780–782
Ueno M, Brookins J, Beckman BS, Fisher JW (1988a) Effects of reactive oxygen metabolites on erythropoietin production in renal carcinoma cells. Biochem Biophys Res Commun 154:773–780
Ueno M, Brookins J, Beckman BS, Fisher JW (1988b) Effects of reactive oxygen metabolites on erythropoietin production in renal carcinoma cells. Biochem Biophys Res Commun 154:773–780
Yasuda H, Kishiro K, Izumi N, Nakanishi M (1985) Biphasic liberation of arachidonic and stearic acid during cerebral ischemia. J Neurochem 45:168–172
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fisher, J.W., Nakashima, J. (1992). Kidney Regulation of Erythropoietin Production. In: Fisher, J.W. (eds) Biochemical Pharmacology of Blood and Bloodforming Organs. Handbook of Experimental Pharmacology, vol 101. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75865-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-75865-2_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-75867-6
Online ISBN: 978-3-642-75865-2
eBook Packages: Springer Book Archive